Dr. Rory and his Gazelle
Dr. Rory and his Gazelle is a story of patient abandonment and treatment refusal. It's sadly common for many patients ...
The Resurgence of Mobile Clinics
Mobile clinics, once a cornerstone of healthcare delivery, are experiencing a resurgence and a renewed focus on access to care.
No, Biden’s Immigration Policies are not to Blame for the Fentanyl Crisis
But this misunderstands the obvious reality about the drug: Because it is so potent, a large supply can be easily ...
SCOTUS Likely to Favor Sackler’s
As the nation grapples with the overdose epidemic, the legal battle surrounding Purdue Pharma's bankruptcy immunity has taken center stage.
Conflating the Migrant and Overdose Crises
While the rhetoric surrounding closing the border may seem appealing, it is essential to critically analyze the potential consequences.
When Patients Go Viral
By understanding the mechanics behind virality, we can better comprehend the influence of social media on medical conversations.
Lonely During the Holidays? You’re Not Alone.
Loneliness has become a widespread issue in today's society, with negative impacts on both our mental and physical health.
Serious About Expanding Access to Methadone
The Senate Committee on Health, Education, Labor, and Pensions is scheduled to consider the Modernizing Opioid Treatment Access Act (MOTAA).
Humility is the Best Medicine
A researcher presents his prescription for better health care: A dose of humility for doctors, nurses and clinicians.
You Might Have Christmas Tree Syndrome
Prolonged exposure to Christmas trees can lead to respiratory and skin health issues, particularly for individuals with asthma or allergies.
Am I Shopping Compulsively?
Compulsive buying during the holiday season can have significant impacts on individuals' mental health and financial well-being.
Have We Cured Sickle Cell Disease?
The development and application of CRISPR-Cas9 bring hope for a cure, addressing the condition at a genetic level.
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more